Dr Scott N Bateman, MD in Sheridan, WY - Medicare Otolaryngology

Dr Scott N Bateman, MD is a medicare enrolled "Otolaryngology" physician in Sheridan, Wyoming. He went to University Of Texas Medical School At San Antonio and graduated in 1990 and has 34 years of diverse experience with area of expertise as Otolaryngology. His current practice location is 330 W Dow St, Sheridan, Wyoming. You can reach out to his office (for appointments etc.) via phone at (307) 672-0290.

Dr Scott N Bateman is licensed to practice in Wyoming (license number 5710A) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1922184647.

Contact Information

	Dr Scott N Bateman, MD
	330 W Dow St, Sheridan, WY 82801-3829
	(307) 672-0290
	(307) 672-0884

Physician's Profile

Full Name	Dr Scott N Bateman
Gender	Male
Speciality	Otolaryngology
Experience	34 Years
Location	330 W Dow St, Sheridan, Wyoming
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Scott N Bateman attended and graduated from University Of Texas Medical School At San Antonio in 1990

NPI Data:

NPI Number: 1922184647
Provider Enumeration Date: 10/27/2006
Last Update Date: 10/13/2010

Medicare PECOS Information:

PECOS PAC ID: 1254314644
Enrollment ID: I20110328000907

Medical Identifiers

Medical identifiers for Dr Scott N Bateman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1922184647	NPI	-	NPPES
116034100	Medicaid	WY
303780	Other	WY	BLUECROSS BLUESHIELD

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	5710A (Wyoming)	Primary
332S00000X	Hearing Aid Equipment	(* (Not Available))	Secondary
207YS0123X	Otolaryngology - Facial Plastic Surgery	5710A (Wyoming)	Secondary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Sheridan Memorial Hospital	Sheridan, WY	Hospital
Johnson County Healthcare Center	Buffalo, WY	Hospital

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Scott N Bateman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Scott N Bateman, MD 330 W Dow St, Sheridan, WY 82801-3829 Ph: (307) 672-0290	Dr Scott N Bateman, MD 330 W Dow St, Sheridan, WY 82801-3829 Ph: (307) 672-0290

News Archive

HHS Secretary, U.S. Attorney General to kick-off Miami fraud prevention summit

On Friday, July 16, U.S. Department of Health and Human Services Secretary Kathleen Sebelius and U.S. Attorney General Eric Holder will kick off the first in a series of day-long summits bringing together a wide array of federal, state, and local partners, beneficiaries, providers, and other interested parties to discuss innovative ways to eliminate fraud within the U.S. health care system. The summit will include educational panels featuring law enforcement officials, consumer experts, providers, and key government agencies.

Researchers explore 3D printing materials to print realistic aorta models

Personalized 3D printed models created from cardiac imaging data, mainly from cardiac CT images have been increasingly used in cardiovascular disease, primarily in the preoperative planning and simulation of complex surgical procedures, as well as medical education.

Seattle Genetics starts Brentuximab Vedotin retreatment trial

Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).

Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics

A drug approved to treat rheumatoid arthritis, tocilizumab (Actemra, Genentech), is a potential new therapy for patients with polymyalgia rheumatica, according to an open-label, phase II study presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals on November 10.

Otolaryngology Doctors in Sheridan, WY

Ms. Cheryl Lynn Varner, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 1333 W 5th St, Ste 206, Sheridan, WY 82801
Phone: 307-675-4646 Fax: 307-675-4645

Dr Scott N Bateman, MD - Medicare Otolaryngology in Sheridan, WY